2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Nuclear Medicine And Molecular Imaging
Nuclear Medicine and Molecular Imaging play pivotal roles in cancer research by offering precise diagnostic and therapeutic approaches. Utilizing radioactive tracers, these techniques allow visualization of cellular functions and molecular pathways, aiding in early detection and precise localization of tumors. Positron Emission Tomography (PET) scans, for instance, provide detailed metabolic information, assisting in treatment planning and monitoring tumor response to therapies. Additionally, targeted radionuclide therapies deliver radiation directly to cancer cells, minimizing damage to surrounding healthy tissue. The integration of advanced imaging modalities with molecular biology has revolutionized cancer management, facilitating personalized treatment strategies and improving patient outcomes. As research continues to evolve, the synergy between nuclear medicine and molecular imaging holds promise for further breakthroughs in cancer diagnosis, treatment, and prognosis.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China